CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a ...

As healthcare spending continues to rise and regulatory pressure intensifies, companies like CVS Health CVS find themselves ...

Good morning, and thank you all for attending the CVS Health Q4 2024 earnings conference call. My name is Brika, and I will ...

Shares of CVS Health (CVS) surged Wednesday morning after the health insurance and pharmacy giant reported ...

Retail pharmacy chain CVS Health (CVS) is scheduled to announce its results for the fourth quarter of 2024 before the market ...

CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings ...

Adjusted earnings for 2025 will be $5.75 to $6 a share, CVS said, while the average estimate of analysts surveyed by ...

CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total ...

CVS Health (CVS) stock was upgraded by Cantor Fitzgerald to Overweight after the company posted strong Q4 results earlier in ...

CVS Health posted Q4 sales of $97.71B, with a 23.3% rise in Health Care Benefits revenue. Fiscal 2025 adjusted EPS guidance ...

For the quarter ended December 2024, CVS Health (CVS) reported revenue of $97.71 billion, up 4.2% over the same period last year. EPS came in at $1.19, compared to $2.12 in the year-ago quarter.

CVS Health reported Q4 revenue of $97.71B, surpassing the $97.19B consensus. 2025 revenue is expected to exceed $134B, driven by higher prescription volumes. Get real-time earnings alerts before ...